Protocolo Brasileiro para Infecções Sexualmente Transmissíveis 2020: infecção pelo papilomavírus humano (HPV)

Carvalho, Newton Sérgio de; Silva, Roberto José Carvalho da; Val, Isabel Chulvis do; Bazzo, Maria Luiza; Silveira, Mariângela Freitas da

doi:10.1590/s1679-4974202100014.esp1

Cited by 14 publications

(21 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Already related to HPV, this is the most transmissible STI, surpassing HIV and genital herpes infections since with each new sexual partner the risk of infection for this pathology is 15% to 25% [15]. Therefore, the importance of analyzing the incidence of HPV is highlighted, to which it is also added that this disease in 99% of cases is associated with the severity of cervical cancer [16].…”

Section: Discussionmentioning

confidence: 99%

Arboviruses and Sexually Transmitted Infections in the Bioceanic Route: Health Indicators in a Municipality

Kowalski¹,

Cunha²,

Ferri³

et al. 2021

AID

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Arboviruses and Sexually Transmitted Infections in the Bioceanic Route: Health Indicators in a Municipality

Kowalski¹,

Cunha²,

Ferri³

et al. 2021

AID

View full text Add to dashboard Cite

“…The HPV vaccine prevents lesions in the female and male genital organs and persistent infections caused by subtypes 6, 11, 16, and 18 of human papillomavirus, with types 16 and 18 considered oncogenic and potentially precursors of cervical cancer. In 2019, 5,880,000 new cases of cervical cancer were reported worldwide 2 ), ( 3 . In Brazil, in 2018 and 2019, approximately 16,370 new cases of cervical cancer were detected, occupying the third place in incidence among malignant tumors 4 .…”

Section: Introductionmentioning

confidence: 99%

Vaccination against human papillomavirus in Brazilian schoolchildren: National Survey of School Health, 2019

Silva

Sá

Prates

et al. 2022

Rev. Latino-Am. Enfermagem

View full text Add to dashboard Cite

Objective: to analyze the prevalence of schoolchildren vaccinated against human papillomavirus (HPV) and the reasons related to non-vaccination. Method: cross-sectional study, with data from the 2019 National Survey of School Health. The sample consisted of 160,721 students aged 13 to 17 years. The prevalence and confidence intervals (95%CI) of vaccinated adolescents were estimated according to location, sex, and administrative dependence of the school. The differences between the strata were evaluated with the Chi-square test. Adjusted prevalence ratios (aPR) and 95%CI were estimated with the Poisson regression model. Results: most of the students were vaccinated (62.9%), and the prevalence of girls (76.1%) was higher than that of boys (49.1%). The most prevalent reason for not vaccinating was “did not know they had to take” (46.8%), with the highest aPR in public schoolchildren in Brazil (1.6; 95%CI 1.5;1.7), from the Northeast region (1.2; 95%CI 1.1;1.2), and in students from private schools in the Northeast regions (1.1; 95%CI 1.1;1.2) and North (1.3; 95%CI 1.2;1.4). Conclusion: one out of every two Brazilian schoolchildren was vaccinated against HPV. Misinformation was a recurring reason for non-vaccination. The North and Northeast regions had the highest prevalence of non-vaccinated people, observed mainly in adolescents from public schools.

show abstract

“…Pois o Ácido Desoxirribonucleico (DNA) se mantém nas células infectadas e pode se permanecer de modo inativo (latente), mesmo sem o aparecimento de sintomas, e após o tratamento ou remoção das lesões, o HPV pode ocasionar ainda a transmissibilidade (10). Por isso é necessário que haja o tratamento efetivo da doença, bem como a redução dos sinais e sintomas (11).…”

Section: Introductionunclassified

Prevalência da coinfecção entre Papilomavírus Humano (HPV) e Chlamydia trachomatis em mulheres

Filho

Silva²,

Oliveira³

et al. 2022

VITTALLE, ISSN 1413-3563, Rio Grande, Brasil

View full text Add to dashboard Cite

O objetivo do estudo foi analisar a prevalência de Papilomavírus Humano (HPV) e Chlamydia trachomatis em mulheres. Foi realizado um estudo documental como dados de mulheres de captura híbrida para HPV e Chlamydia trachomatis. Os dados foram analisados pelo programa estatístico Epi Info, utilizou-se o Qui-Quadrado e Razão de Chances com intervalos de 95% de confiança (IC 95). Foi considerado de significância estatística o valor p associado menor ou igual a 0,05 (p≤0,05). Trezentas e treze mulheres, 24,6% apresentaram positividade para HPV, 10,9% para Chlamydia e 3,5% para co-infecção. O HPV foi de 85,7% para mulheres com diagnóstico de ASCUS, 80% com LSIL, 100% com ASCH e HSIL, e 21,4% com citologia normal. Para CT, no exame citopatológico, foi de 28,6% para mulheres com diagnóstico de ASCUS, 10% com LSIL e 10,5% com citologia normal. A frequência de co-infecção foi maior em mulheres com idade inferior ou igual a 32 anos. No exame citopatológico, 18,2% tiveram diagnóstico para ASCUS, 9,1% para LSIL e 72,7% para citologia normal. Os dados encontrados sugerem estratégias de esclarecimentos sobre a prevenção e agravos relacionados a essas IST, bem como incentivo do rastreamento e a importância da biologia molecular na detecção dessas duas IST.

show abstract

Protocolo Brasileiro para Infecções Sexualmente Transmissíveis 2020: infecção pelo papilomavírus humano (HPV)

Cited by 14 publications

References 39 publications

Arboviruses and Sexually Transmitted Infections in the Bioceanic Route: Health Indicators in a Municipality

Arboviruses and Sexually Transmitted Infections in the Bioceanic Route: Health Indicators in a Municipality

Vaccination against human papillomavirus in Brazilian schoolchildren: National Survey of School Health, 2019

Prevalência da coinfecção entre Papilomavírus Humano (HPV) e Chlamydia trachomatis em mulheres

Contact Info

Product

Resources

About